Correlation Between Advanced Glycation End Products and Gastric Motility Disorder in Diabetes Gastroparesis

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-75
SponsorNorthern Jiangsu People's Hospital

About this trial

This study is a prospective observational study. The study will explore the correlation between advanced glycation end products and gastric motility disorder in diabetic gastroparesis(DGP) through the collection of blood and gastric tissue samples and relevant data of patients with DGP and control group patients without diabetes history and gastroparesis symptoms.

Eligibility criteria

Qualifiers

Meet the diagnostic criteria for diabetes

Presence of symptoms (see assessment of Gastroparesis Cardinal Symptom Index)

Age range from 18 to 75 years old

Voluntarily participate and sign an informed consent form

Disqualifiers

Currently taking prokinetic drugs, anticholinergic drugs, and dopamine drugs that may affect gastric motility

Has a history of gastrointestinal surgery

Pregnant or preparing to conceive

There are neurological disorders such as Parkinson's disease that affect gastrointestinal function

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

50 Participants
are grouped into 2 trial groups